Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-035606
Filing Date
2023-03-22
Accepted
2023-03-22 16:20:14
Documents
1
Period of Report
2023-03-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2310075-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2310075-3_4seq1.xml 4 4153
  Complete submission text file 0001104659-23-035606.txt   5761
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB
Business Address 1ST FLOOR, VIKING HOUSE ST PAULS SQUARE, RAMSEY Y8 IM8 1GB 441624639396
Juvenescence Ltd (Reporting) CIK: 0001724307 (see all company filings)

State of Incorp.: Y8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38519 | Film No.: 23753198